Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 376 - 400 of 475 in total
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
An organoselenium drug previously studied by Oxis International in Phase-II clinical trials for ulcerative colitis patients. Some indications of efficacy were demonstrated. BXT-51072 has enthusiastic endorsement for treatment in cardiovascular indications, primarily because of its ability to mimic the function of glutathione peroxidase.
Investigational
Matched Categories: … Selenium Compounds …
Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).
Investigational
Matched Categories: … Selenium Compounds …
Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Investigational
Matched Categories: … Ion Pumps ... Ion Channels …
IONIS-HBVRx is under investigation in clinical trial NCT04544956 (A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B).
Investigational
GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity.
Investigational
Matched Description: … GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity …
Sapablursen is a synthetic 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid
Investigational
Experimental
Matched Iupac: … iron(3+) ion trihydroxide …
Experimental
Matched Iupac: … (67Ga)gallium(3+) ion
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Iupac: … lambda5-antimony(5+) ion
Experimental
Matched Iupac: … magnesium(2+) ion dioxidanediide …
Experimental
Matched Iupac: … dicerium(3+) ion trioxalate …
Experimental
Matched Iupac: … (89Sr)strontium(2+) ion
Experimental
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.
Investigational
Matched Categories: … Selenium Compounds …
CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials as a novel compound for the treatment of neuropathic pain.
Investigational
Matched Description: … CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials …
A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. (From Merck Index, 11th ed)
Experimental
Matched Description: … A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. …
Experimental
Vet approved
Matched Iupac: … dibismuth(3+) ion carbonate dioxidandiide …
Displaying drugs 376 - 400 of 475 in total